BCLA Clinical Conference & Exhibition on 9 – 11 June 2023
During this international conference in Manchester, you could hear the latest updates on contact lenses innovations and developments, and have opportunities to build your network.
We are proud to be a Platinum Sponsor at this year’s BCLA Clinical Conference & Exhibition. We shared lots of exciting things and we loved to hear your perspectives on a whole host of clinical and scientific content that we shared at this year’s event.
Like you, we’re passionate about improving the way people see each day
Recap of our BCLA Breakfast meeting
We were pleased to have our panel discussion at our BCLA breakfast meeting: Speciality lenses – personalised eyecare that can transform lives.
Global industry experts and high street practice evangelists came together to share why they love speciality lenses. They discussed how they have integrated speciality lenses into daily clinics, their positive impact on patients, and the business-building opportunities they've presented. And for the cherry on the breakfast muffin - we launched our new EyeDream® MC lens - an ortho-k lens specifically designed for myopia management!*
By embracing specialty designs and providing personalised care, we enhance not only our patients' vision but their sense of well-being.
Orthokeratology
CooperVision’s extensive orthokeratology range offers effective myopia management1,2, alongside the freedom of being lens and spectacle free in the day: DreamLite® MC night lenses (EyeDream® MC in UK*) and Paragon CRT® Contact Lenses.
Benefits of wearing ortho-k:
• Sharp vision all day without needing glasses or contact lenses, ultimate freedom in sports and play.
• Safe with fully reversible correction.3
• Clinical studies prove that ortho-k lenses deliver life changing benefits including better classroom performance, greater self-esteem, improved social skills and greater participation in sports.4
Innovation in myopia management
It is predicted that by 2050 more than 50% of the global population will be myopic.5 As ECPs it is critical that we act to protect the visual health of our young patients. Together, we can make the difference and make myopia management the standard of care for children across the world.
As a Myopia Management Expert, we will provide you with the tools, resources and optical interventions you need to offer a customised, patient-centred approach to myopia management. Our Myopia Management options include - MiSight® 1 day, SightGlass Vision™, DreamLite® MC, Paragon CRT and EyeDream® MC.
About CooperVision Specialty EyeCare
CooperVision Specialty EyeCare (SEC) is a division of CooperVision that produces specialty contact lenses. SEC develops, manufacturers, and provides access to a portfolio of industry leading soft custom and rigid gas permeable lens designs, including orthokeratology and scleral lenses to address segments such as myopia management, irregular cornea management and presbyopia management. Its steady voice, ongoing research, academy and innovative products and services play a leading role in expanding care worldwide.
Discover the opportunities in your region:
• BNL
• EMEA
• NORDICS
• UK
Ask your question
Do you want to know more about specialty contact lenses or have any questions? Our team is happy to help!
1. Charm, J & Cho; High Myopia-Partial Reduction Ortho-k A 2-year randomized study; Optometry and Vision Science; Vol 90; No 6 P530-539; 2013.
2. Jakobsen Trine Moldrup et al., Clinical study of near-Sightedness; Treatment with Orthokeratology Lenses (CONTROL study): Acta Ophthalmologica 2021.
3. Vincent et al., (2021). BCLA CLEAR - Orthokeratology. Contact Lens and Anterior Eye, 44(2), 240-269. https://doi.org/10.1016/j.clae.2021.02.003.
4. F. Z., G. Z., & Z. Z. (2018). Investigation of the Effect of Orthokeratology Lenses on Quality of Life and Behaviors of Children. Contact Lens Association of Ophthalmologists, Inc., 44(5). Retrieved May 8, 2019.
5. Holden BA, Fricke TR, Wilson DA et al. Global Prevalence of Myopia and High Myopia and Temporal Trends from 2000 through 2050. Ophthalmology. 2016; 123:1036-42.
*EyeDream® MC (powered by DreamLite® MC) will be launched during breakfast workshop SEC at BCLA.
